GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.01 $4.17 Friday, 19th Apr 2024 CLRB stock ended at $3.03. This is 0.329% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 4.98% from a day low at $3.01 to a day high of $3.16.
90 days $3.01 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2024-03-14 $3.54 $3.56 $3.38 $3.38 985 441
2024-03-13 $3.61 $3.72 $3.54 $3.54 483 578
2024-03-12 $3.79 $3.79 $3.60 $3.63 652 801
2024-03-11 $3.99 $4.05 $3.76 $3.77 750 266
2024-03-08 $4.08 $4.22 $3.93 $4.00 1 273 716
2024-03-07 $4.00 $4.13 $3.97 $4.07 741 139
2024-03-06 $4.10 $4.22 $3.98 $4.00 966 801
2024-03-05 $4.21 $4.34 $4.02 $4.05 1 075 802
2024-03-04 $4.40 $4.45 $3.94 $4.24 2 962 315
2024-03-01 $4.00 $4.20 $3.93 $4.20 804 722
2024-02-29 $4.00 $4.04 $3.86 $3.92 404 884
2024-02-28 $3.85 $4.13 $3.78 $3.94 1 641 037
2024-02-27 $3.57 $3.95 $3.54 $3.88 1 945 549
2024-02-26 $3.35 $3.51 $3.35 $3.49 1 168 943
2024-02-23 $3.35 $3.37 $3.24 $3.34 875 242
2024-02-22 $3.37 $3.49 $3.34 $3.35 554 622
2024-02-21 $3.29 $3.35 $3.25 $3.28 528 990
2024-02-20 $3.43 $3.47 $3.25 $3.29 1 060 254
2024-02-16 $3.58 $3.62 $3.44 $3.45 515 454
2024-02-15 $3.50 $3.64 $3.43 $3.59 1 137 615
2024-02-14 $3.44 $3.59 $3.38 $3.50 705 260
2024-02-13 $3.41 $3.48 $3.33 $3.39 1 291 823
2024-02-12 $3.50 $3.54 $3.43 $3.50 914 172
2024-02-09 $3.53 $3.58 $3.47 $3.50 458 355
2024-02-08 $3.51 $3.62 $3.46 $3.51 548 109
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT